| Primary |
| Pulmonary Arterial Hypertension |
30.9% |
| Erectile Dysfunction |
11.4% |
| Pulmonary Hypertension |
9.4% |
| Prophylaxis |
8.0% |
| Hypertension |
6.1% |
| Diabetes Mellitus |
3.9% |
| Interstitial Lung Disease |
3.9% |
| Depression |
2.8% |
| Cardiac Failure |
2.7% |
| Pulmonary Fibrosis |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Anaemia |
2.2% |
| Hypokalaemia |
2.1% |
| Hyperuricaemia |
1.9% |
| Bronchiectasis |
1.8% |
| Skin Ulcer |
1.8% |
| Supplementation Therapy |
1.8% |
| Osteoporosis |
1.6% |
| Systemic Lupus Erythematosus |
1.5% |
| Angina Pectoris |
1.3% |
|
| Cardiac Failure |
9.7% |
| Syncope |
9.7% |
| Vision Blurred |
7.8% |
| Death |
6.8% |
| Epistaxis |
6.8% |
| Pneumonia |
5.8% |
| Pulmonary Oedema |
5.8% |
| Glaucoma |
4.9% |
| Oesophageal Achalasia |
4.9% |
| Breast Cancer Recurrent |
3.9% |
| Chorioretinopathy |
3.9% |
| Loss Of Consciousness |
3.9% |
| Off Label Use |
3.9% |
| Tachycardia |
3.9% |
| Urinary Tract Infection |
3.9% |
| Cardiac Failure Congestive |
2.9% |
| Depression |
2.9% |
| Infection |
2.9% |
| Pulmonary Hypertension |
2.9% |
| Visual Disturbance |
2.9% |
|
| Secondary |
| Pulmonary Arterial Hypertension |
43.9% |
| Product Used For Unknown Indication |
8.0% |
| Drug Use For Unknown Indication |
7.3% |
| Hypertension |
6.7% |
| Diabetes Mellitus |
5.0% |
| Pulmonary Hypertension |
4.1% |
| Erectile Dysfunction |
3.7% |
| Prophylaxis |
2.3% |
| Anaemia |
2.1% |
| Bronchiectasis |
2.1% |
| Pulmonary Fibrosis |
2.1% |
| Hypokalaemia |
1.6% |
| Pneumonia |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Constipation |
1.4% |
| Fluid Retention |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Interstitial Lung Disease |
1.4% |
| Depression |
1.2% |
| Hyperuricaemia |
1.2% |
|
| Syncope |
15.6% |
| Fluid Retention |
9.4% |
| Pulmonary Oedema |
8.3% |
| Cardiac Failure |
5.2% |
| Completed Suicide |
5.2% |
| Oesophageal Achalasia |
5.2% |
| Respiratory Arrest |
5.2% |
| Toxicity To Various Agents |
5.2% |
| Hypoxia |
4.2% |
| Liver Disorder |
4.2% |
| Pulmonary Hypertension |
4.2% |
| Supraventricular Tachycardia |
4.2% |
| Acute Myocardial Infarction |
3.1% |
| Infection |
3.1% |
| Lung Infection |
3.1% |
| Oedema Peripheral |
3.1% |
| Systemic Sclerosis |
3.1% |
| Urinary Tract Infection |
3.1% |
| Vomiting |
3.1% |
| Acute Respiratory Failure |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.9% |
| Pulmonary Arterial Hypertension |
25.6% |
| Drug Use For Unknown Indication |
10.0% |
| Erectile Dysfunction |
5.4% |
| Hypertension |
4.7% |
| Pulmonary Hypertension |
2.9% |
| Diabetes Mellitus |
2.6% |
| Hiv Infection |
2.5% |
| Hyperlipidaemia |
2.5% |
| Prostate Cancer |
2.5% |
| Type 2 Diabetes Mellitus |
2.2% |
| Pain |
2.0% |
| Vitamin Supplementation |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Prophylaxis |
1.2% |
| Asthma |
1.2% |
| Nausea |
1.1% |
| Parkinson's Disease |
1.1% |
| Rheumatoid Arthritis |
1.1% |
| Gout |
1.0% |
|
| Death |
16.1% |
| Dyspnoea |
12.5% |
| Vomiting |
8.9% |
| Cardiac Failure |
5.7% |
| Syncope |
5.7% |
| Respiratory Failure |
5.2% |
| Pulmonary Arterial Hypertension |
4.7% |
| Pyrexia |
4.2% |
| Blood Potassium Decreased |
3.6% |
| Nausea |
3.6% |
| Weight Increased |
3.6% |
| Lip Swelling |
3.1% |
| Oedema Peripheral |
3.1% |
| Palpitations |
3.1% |
| Pneumonia |
3.1% |
| Right Ventricular Failure |
3.1% |
| Atrial Fibrillation |
2.6% |
| Chest Pain |
2.6% |
| Dehydration |
2.6% |
| Fluid Overload |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Hypertension |
30.0% |
| Blood Pressure |
10.0% |
| Erectile Dysfunction |
10.0% |
|
| Hypertension |
50.0% |
| Pain In Jaw |
50.0% |
|
